« Return to News | CROs/Service Providers

Acurian Beefs Up Data Modeling Capabilities for Patient Recruitment

Thursday, August 14, 2008 09:00 AM

Patient recruitment provider Acurian is increasing its data modeling capabilities, a move that chief information officer and vice president of operations Roger Smith says benefits not just Acurian but the entire industry.

“Too many sponsors are forced to rely on anecdotal or no data--before, during and after a patient recruitment campaign,” explained Smith in a company release. “So while we’ve made significant investments in analytical data expertise and technologies to help us run the only performance-based recruitment business in the industry, our customers are the true beneficiaries. Our data experts and tools help sponsors better understand the enrollment continuum from response to randomization so that there are no surprises in timelines or budget allocations.”

Acurian’s increased investments in data modeling personnel and technology will improve the sponsor’s ability to develop and analyze patient recruitment campaigns.

By looking at key variables such as protocol logistics, inclusion/exclusion criteria, screen fail rates, site performance, response rates, and referral rates, Acurian’s modeling services can graph the impact of a centralized recruitment campaign from one or more suppliers across a given timeframe, Smith said. The model provides sponsors with real-time projections throughout the enrollment process.

“We are putting an end to the days where a sponsor’s patient recruitment allocations go into a black hole and accountability is subservient to activity,” Smith said in the release.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.